Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs

July 8 (Reuters) - Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to ...
Medical News Today

Anoro Ellipta

Anoro Ellipta side effects Anoro Ellipta can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Anoro Ellipta. These lists do not ...

Sino Biopharma receives Chinese rights to two GSK respiratory drugs

A unit of Sino Biopharmaceutical (SBMFF) has obtained commercialization rights to market two GSK (GSK)-owned respiratory drugs in mainland China, the Hong Kong-listed drugmaker announced on Wednesday.
Pharmabiz

Sino Biopharma’s subsidiary, CTTQ further deepens the exclusive strategic collaboration with GSK

Sino Biopharma’s subsidiary, CTTQ further deepens the exclusive strategic collaboration with GSK: Hong Kong Friday, July 10, 2026, 16:00 Hrs [IST] Sino Biopharmaceutical Limited ...
Healthline

Anoro Ellipta and Cost: What You Need to Know

Anoro Ellipta (umeclidinium/vilanterol) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). Anoro Ellipta’s cost may depend ...